Table 2.
Association with in-hospital mortality: univariate Cox regression analysis adjusted for age, sex, and frailty.
HR (95%CI) | |
---|---|
Comorbidities | |
Diabetes Mellitus | 0.86 (0.54–1.37) |
Hypertension | 0.82 (0.54–1.24) |
Atrial Fibrillation | 1.34 (0.90–1.99) |
Dementia | 1.01 (0.68–1.50) |
Chronic Lung Diseases | 1.43 (0.91–2.23) |
Myocardial Infarction | 1.49 (0.37–6.08) |
Concurrent Bacterial Infection | 0.77 (0.37–1.59) |
Stroke | 0.68 (0.32–1.48) |
Dyslipidemia | 0.64 (0.41–0.99) |
Lab Parameters | |
NT-proBNP (pg/mL) | 1.000028 (1.000015–1.000041) |
Creatinine (mg/dL) | 1.11 (1.04–1.19) |
Neutrophil count (n/microl) | 1.10 (1.07–1.13) |
eGFR (ml/min/1.73 m2) | 0.98 (0.97–0.99) |
CRP (mg/dL) | 1.07 (1.05–1.10) |
Systolic BP (mmHg) | 0.99 (0.98–1.00) |
Cluster (ref. 1) | |
2 | 1.96 (1.28–3.01) |
3 | 2.87 (1.62–5.07) |
Bold indicates significance. Dyslipidemia, hypertension, chronic lung diseases, and diabetes mellitus were defined according to individual medical history and/or respective treatments taken at home. Atrial fibrillation, myocardial infarction, and stroke are referred to as previous events in the history of the patient. Laboratory parameters and blood pressure are expressed as continuous variables. HRs for diabetes mellitus, hypertension, atrial fibrillation, dementia, myocardial infarction, concurrent bacterial infection, stroke, and dyslipidemia refer to the presence of disease in reference to the absence of disease. NT-proBNP: N-terminal pro-B-type natriuretic peptide; eGFR: estimated glomerular filtration rate; CRP: C-reactive protein; BP: blood pressure.